News in the Life Sciences Industry

STOCKHOLM, May 6, 2019 /PRNewswire/ --The study, which evaluated standard hormonal therapies in metastatic breast cancer, used the DiviTum® blood test as a non-invasive tool to monitor therapy efficacy. A total of 244 patients had their blood samples analyzed with DiviTum® and the study found... Read more ››

STOCKHOLM, May 6, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today informs that new data from the phase II program of MIV-711, has been presented as a poster during the Osteoarthritis Research Society International (OARSI) world congress. The poster title was Safety and... Read more ››

STOCKHOLM, May 3, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical-technology company, today announced that the company's nomination committee recommends Ms. Catherine Gilmore-Lawless to be a new IRRAS board member.

STOCKHOLM, May 3, 2019 /PRNewswire/ -- Enzymatica has now finalized the enrolment to its prospective double-blind, placebo-controlled multicentre study to evaluate the effects of ColdZyme® on the common cold. In total about 700 patients have been enrolled at ten study centres... Read more ››